Search

Author/Creator Moessner, R.

1. One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis. (February 2014)

Authors:
Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Brunori, M.; Mistry, S.; Bergmans, P.; Barker, J.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M.
Journal:
British journal of dermatology
Issue:
Volume 170:Number 2(2014:Feb.)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis. (1st February 2014)

Authors:
Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Brunori, M.; Mistry, S.; Bergmans, P.; Barker, J.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M.
Journal:
British journal of dermatology
Issue:
Volume 170:Number 2(2014:Feb.)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants. (14th September 2021)

Authors:
Eap, C. B.; Gründer, G.; Baumann, P.; Ansermot, N.; Conca, A.; Corruble, E.; Crettol, S.; Dahl, M. L.; de Leon, J.; Greiner, C.; Howes, O.; Kim, E.; Lanzenberger, R.; Meyer, J. H.; Moessner, R.; Mulder, H.; Müller, D. J.; Reis, M.; Riederer, P.; Ruhe, H. G.
Journal:
World journal of biological psychiatry
Issue:
Volume 22:Number 8(2021)
Page Start:
561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (1st February 2014)

Authors:
Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M.
Journal:
British journal of dermatology
Issue:
Volume 170:Number 2(2014:Feb.)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). (February 2014)

Authors:
Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.‐F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.; Adamski, Z.; Altomare, G.; Aricò, M.; Aste, N.; Aubin, F.; Augustin, M.
Journal:
British journal of dermatology
Issue:
Volume 170:Number 2(2014:Feb.)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗